Showing results (1-10 of 48) with videos related to
Sort By:
Pageof 5
Current Hematologic Malignancy Reports|March 17, 2012
Antibody therapy for acute lymphoblastic leukemiaCraig A Portell, Anjali S AdvaniCurrent Treatment Options in Oncology|May 16, 2015
The role of infectious agents, antibiotics, and antiviral therapy in the treatment of extranodal marginal zone lymphoma and other low-grade lymphomasLaahn H Foster, Craig A PortellCancer Journal (Sudbury, Mass.)|September 26, 2012
Adult lymphoblastic lymphomaCraig A Portell, John W SweetenhamLeukemia & Lymphoma|July 12, 2013
Novel targeted therapies in acute lymphoblastic leukemiaCraig A Portell, Anjali S AdvaniBest Practice & Research. Clinical Haematology|February 18, 2018
Novel therapies for relapsed/refractory mantle cell lymphomaPuja C Arora, Craig A PortellClinical Lymphoma, Myeloma & Leukemia|February 7, 2026
SOHO State of the Art Updates and Next Questions | Sequencing Therapies in Relapsed/Refractory Mantle Cell LymphomaJean M Clement, Craig A PortellClinical Lymphoma, Myeloma & Leukemia|November 6, 2025
Maintenance Rituximab Following Rituximab Induction for Follicular Lymphoma: A Single-Center ExperienceLukas L Lauer, Craig A PortellBlood Reviews|May 31, 2023
Central nervous system prophylaxis in diffuse large B-cell lymphoma: What does the evidence tell us?Jeffrey Lantz, Craig A Portell, Emily C AyersClinical Pharmacology : Advances and Applications|May 15, 2013
Clinical and pharmacologic aspects of blinatumomab in the treatment of B-cell acute lymphoblastic leukemiaCraig A Portell, Candice M Wenzell, Anjali S AdvaniCurrent Oncology Reports|July 16, 2021
Leukemic Variant of Mantle Cell Lymphoma: Clinical Presentation and ManagementKrista M Isaac, Craig A Portell, Michael E WilliamsPageof 5